Below is a summary of our recent news. Click any post title or the read more link below any story to see more!
On Friday, Dec. 13th, the FDA's Dermatologic and Ophthalmic Drugs Advisory Committee met in Silver Spring, MD to discuss teprotumumab, a potential treatment for active thyroid eye disease.
Wishing everyone a beautiful Holiday season and a healthy, happy New Year!
Did you know that your regular online holiday shopping can help the GDATF fund its patient education and support programs? By purchasing through one of the following channels, online retailers will donate a portion of proceeds to the Graves’ Disease & Thyroid Foundation - at no cost to you!
Amazon Smile Program
We're headed to the American Thyroid Association's 89th Annual Meeting in Chicago, IL, which will include a public patient forum on Saturday, November 2nd. This event is hosted by the American Thyroid Association (ATA) Alliance for Patient Education, and will be a great opportunity for patients to interact with advocates and physicians in an informal setting. Click here for details and registration!
Please join us in Denver, CO on October 20th for a patient education seminar on Graves' disease and thyroid eye disease! The event is free, but advance registration is requested to reserve space.
We'd like to thank our friends at ThyCa: Thyroid Cancer Survivors', Inc. for the opportunity to host this meeting during their annual conference. If you or a loved one has been impacted by thyroid cancer, please consider attending the full ThyCa conference from Oct. 18-20!